QCG
TIL icon

Quadrant Capital Group’s Instil Bio TIL Stock Holding History

Quadrant Capital Group’s Portfolio TIL Stock Details TIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-5
Closed -$1K – 2853
2022
Q3 		$1K Hold
5
– – ﹤0.01% 2568
2022
Q2 		$1K Sell
5
-1,340
-100% -$190K ﹤0.01% 2455
2022
Q1 		$289K Buy
+1,345
New +$314K 0.04% 352

Other funds holding TIL

CVV
Curative Ventures V Dallas, Texas $15.6M AUM 52.53% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CI
CPMG Inc Dallas, Texas $37.1M AUM 74.35% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Quadrant Capital Group's TIL Position: Q4 2022 in Review

Quadrant Capital Group sold out of Instil Bio (TIL) in Q4 2022, closing a stake of 5 shares — an estimated $1K sold.

Quadrant Capital Group first reported a position in TIL in Q1 2022 and held it in 3 quarters. The position peaked at $289K in Q1 2022. 78 funds tracked by Wall St. Rank hold TIL as of Q4 2022.

  • Quadrant Capital Group reported no remaining Instil Bio position as of Q4 2022 after selling out during the quarter.
  • Quadrant Capital Group sold 5 Instil Bio shares in Q4 2022, an estimated $1K.
  • Quadrant Capital Group first reported a position in Instil Bio in Q1 2022 and held it in 3 quarters.
  • Quadrant Capital Group's Instil Bio position peaked at $289K in Q1 2022.
  • 78 funds tracked by Wall St. Rank held Instil Bio as of Q4 2022.

Based on Quadrant Capital Group's 13F filing for Q4 2022, filed 13 Feb 2023.